AVROBIO has obtained $60 million in additional financing to start a Phase 2 clinical trial of its gene therapy for…
Alice Melao
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.